William K. Evans, MD, FRCPC, Yee C

Slides:

Advertisements

Similar presentations

Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,

Advertisements

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages

Quality Improvement in Cancer Symptom Assessment and Control: The Provincial Palliative Care Integration Project (PPCIP) Julie E. Gilbert, MSc, PhD, Doris.

The Accuracy of Frozen Section Diagnosis of Pulmonary Nodules: Evaluation of Inflation Method during Intraoperative Pathology Consultation with Cryosection.

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab Monica Khunger, MD Journal of Thoracic.

Kazuma Nagata, MD, Reiko Kaji, MD, Keisuke Tomii, MD

Characteristics and Outcomes of Small Cell Lung Cancer Patients Diagnosed During Two Lung Cancer Computed Tomographic Screening Programs in Heavy Smokers

Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease Eisaku.

Hironori Yoshida, MD, Young Hak Kim, MD Journal of Thoracic Oncology

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

EGFR and KRAS Mutations in Triple-Mutated Lung Cancer

Positron Emission Tomography-Computed Tomography Compared with Invasive Mediastinal Staging in Non-small Cell Lung Cancer: Results of Mediastinal Staging.

Mark F. Berry, MD, Thomas A. Sporn, MD, Joseph O. Moore, MD, Thomas A

Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.

Joachim Pfannschmidt, MD, Hans Hoffmann, MD, Hendrick Dienemann, MD

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab Monica Khunger, MD Journal of Thoracic.

ACR Select Identifies Inappropriate Underutilization of Magnetic Resonance Imaging in British Columbia Kathleen Eddy, MD, Adam Beaton, MA, Richard Eddy,

James E. Novak, Khalid Alamiri, Jerry Yee

Electronic Updates for JTO Readers

Hedgehog Signaling Pathway and Lung Cancer

Hironori Yoshida, MD, Young Hak Kim, MD Journal of Thoracic Oncology

Dramatic Response to Pemetrexed in a Patient with Pneumonic-Type Mucinous Bronchioloalveolar Carcinoma David H. Garfield, MD, Wilbur Franklin, MD Journal.

Frank Detterbeck, MD Journal of Thoracic Oncology

Successful Treatment with Erlotinib after Gefitinib-Induced Severe Interstitial Lung Disease Masayuki Takeda, MD, PhD, Isamu Okamoto, MD, PhD, Chihiro.

A Case of Invasive Mucinous Pulmonary Adenocarcinoma with a CD74-NRG1 Fusion Protein Targeted with Afatinib Parneet K. Cheema, MD, MBiotech, FRCPC Journal.

Follow-Up of Patients after Stereotactic Radiation for Lung Cancer: A Primer for the Nonradiation Oncologist Kitty Huang, MSc, MDCM, David A. Palma,

Effective Treatment with Icotinib in Primary Adenoid Cystic Carcinoma of the Lung with Liver Metastasis Zhengbo Song, MD, Wei Wu, MD, Yiping Zhang, MD

Jeffrey Bradley, MD, Issam El Naqa, PhD Journal of Thoracic Oncology

Quality Improvement in Cancer Symptom Assessment and Control: The Provincial Palliative Care Integration Project (PPCIP) Julie E. Gilbert, MSc, PhD,

Association between Congenital Lung Malformations and Lung Tumors in Children and Adults: A Systematic Review Arianna Casagrande, MD, Federica Pederiva,

Disease Flare After Treatment Discontinuation in a Patient With EML4-ALK Lung Cancer and Acquired Resistance to Crizotinib Oana Pop, MD, Augustin Pirvu,

“The Best-Laid Plans … Often go Awry …”

Jeffrey T. Yorio, MD, Yang Xie, PhD, Jingsheng Yan, PhD, David E

Imaging Requirements in the Practice of Pulmonary Metastasectomy

Daniel Morgensztern, MD, Boone Goodgame, MD, Maria Q

Thomas Henzler, MD, Ishar-Singh Gill, MD, Radko Krissak, MD, Stefan O

Clinicopathological Characteristics of Screen-Detected Lung Cancers

Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response

Four-Year Complete Remission in a Patient with Metastatic Epidermal Growth Factor Receptor–Mutated Lung Cancer Treated with Two Cycles of Erlotinib Brendan.

Time to Treat: A System Redesign Focusing on Decreasing the Time from Suspicion of Lung Cancer to Diagnosis Dorothy S. Lo, MD, Robert A. Zeldin, MD,

Elizabeth Cathcart-Rake, MD, Ariel Lopez-Chavez, MD, MS

Positron Emission Tomography 18F-Fluorodeoxyglucose Uptake and Prognosis in Patients with Surgically Treated, Stage I Non-small Cell Lung Cancer: A Systematic.

Jennifer L. Dallas, MD, Michael A. Jantz, MD, Judith L

Ayman O. Soubani, MD, John C. Ruckdeschel, MD

Mirror Mirror on the Wall, Who Is the Fairest of Them All

Pulmonary Metastasectomy in Breast Cancer

Nicholas W. Choong, MD, Robert S. Hellman, MD

T4 or MI? Journal of Thoracic Oncology Volume 6, Issue 3, (March 2011)

M. Kusumoto Journal of Thoracic Oncology

Two Generations of Light/Never-Smokers With Advanced Adenocarcinoma of the Lung with Durable Responses to Erlotinib Nathan A. Pennell, MD, PhD, Lihong.

Jie Huang, Juan Peng, Linlang Guo, MD, PhD

High Frequency of Radiation Pneumonitis in Patients with Locally Advanced Non-small Cell Lung Cancer Treated with Concurrent Radiotherapy and Gemcitabine.

Antiangiogenesis Induced Tumor Cavitation in Lung Cancer

Genetic Changes in Squamous Cell Lung Cancer: A Review

Marianna Koczywas, MD, Mihaela C. Cristea, MD

European Lung Cancer Conference (ELCC) 2016 Organisation

Impressive Response to Tyrosine Kinase Inhibitors in a Patient with Respiratory Failure for EGFR-Mutated Metastatic Lung Cancer Elena Bolzacchini, MD,

Tetsuzo Tagawa, MD, Miyuki Takasu, MD, Teruyoshi Ishida, MD

Metastatic Lung Cancer to the Pancreas

Follow-Up of Small (4 mm or Less) Incidentally Detected Nodules by Computed Tomography in Oncology Patients: A Retrospective Review Reginald F. Munden,

Intrathoracic Desmoid Tumor: Brief Report and Review of Literature

Acquired Mechanism of Crizotinib Resistance in NSCLC with MET Exon 14 Skipping Wei Jin, MD, Benjie Shan, MD, Hu Liu, PhD, Shoubing Zhou, PhD, Wenjuan.

APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28

Quality Improvement in Cancer Symptom Assessment and Control: The Provincial Palliative Care Integration Project (PPCIP) Julie E. Gilbert, MSc, PhD,

Preoperative PFTs: The answer is blowing in the wind

Lack of FDG Uptake in Small Cell Carcinoma Associated with ANNA-1 Positive Paraneoplastic Autonomic Neuropathy Matthew S. Block, MD, PhD, Robert Vassallo,

A Review of First-Line Treatment for Small-cell Lung Cancer

Razvan Diaconescu, MD, Chantal Lafond, MD, Renaud Whittom, MD

Robert Comis, MD, The Passing of a “Lung Man”

Ana Luque, MD, Edurne Arriola, MD, PhD Journal of Thoracic Oncology

Presentation transcript:

Improving the Quality of Lung Cancer Care in Ontario: The Lung Cancer Disease Pathway Initiative William K. Evans, MD, FRCPC, Yee C. Ung, MD, FRCPC, Nathalie Assouad, BSc, MBA, Anna Chyjek, BSc, CCRA, Carol Sawka, MD, FRCPC Journal of Thoracic Oncology Volume 8, Issue 7, Pages 876-882 (July 2013) DOI: 10.1097/JTO.0b013e31828cb548 Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 Lung Cancer Diagnosis Pathway. CT, computed tomography MRI, magentic resonance imaging, CBC, complete blood count; INR, international normalized ratio; PFT, pulmonary function test; PTT, partial thromboplastin time. Journal of Thoracic Oncology 2013 8, 876-882DOI: (10.1097/JTO.0b013e31828cb548) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 2 Symptom profile for Ontario lung cancer patients using the Edmonton Symptom Assessment System. Journal of Thoracic Oncology 2013 8, 876-882DOI: (10.1097/JTO.0b013e31828cb548) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions